OQROGet OQRO Pro
Insider trade

Immuneering (IMRX)CHIEF SCIENTIFIC OFFICER bought ~$15K

Brett Matthew Hall, CHIEF SCIENTIFIC OFFICER at Immuneering, bought ~$15K of Immuneering shares.

~$15K
Approx. value · 6,007 sh @ $2.43
359K
Holds after · shares reported
Traded
Jun 23, 2025
Filed
Jun 24, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 17, 2025InsiderDirector purchased ~$89K of IMRX shares in the open market
  2. Jun 18, 2025Insider · 2 peopleInsiders: 2 purchases (~$113K)
  3. Jun 20, 2025Insider · 2 peopleInsiders: 2 purchases (~$25K)
  4. Jun 23, 2025 · this disclosureInsiderOfficer purchased ~$15K of IMRX shares in the open market

What came next

  1. Jun 27, 2025InsiderDirector purchased ~$35K of IMRX shares in the open market
  2. Jul 1, 2025InsiderCEO purchased ~$10K of IMRX shares in the open market
  3. Jul 2, 2025Insider · 3 peopleInsiders: 4 purchases (~$47K)
  4. Sep 24, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
  5. Sep 24, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  6. Sep 29, 2025InsiderDirector purchased ~$36K of IMRX shares in the open market
  7. Oct 3, 2025InsiderDirector purchased ~$50K of IMRX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Immuneering

OQRO holds no insider, Congress, fund or contract record for Immuneering dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IMRX page.

Other recent filings by Brett Matthew Hall, CHIEF SCIENTIFIC OFFICER

The full history of Brett Matthew Hall, CHIEF SCIENTIFIC OFFICER is on the profile page.

How this filing works

Other disclosures at Immuneering

Everything OQRO holds on this company is on its IMRX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data